Navigation Links
Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products
Date:10/9/2007

COLORADO SPRINGS, Colo., Oct. 9 /PRNewswire-FirstCall/ -- Spectranetics Corporation (Nasdaq: SPNC) today announced it has received reimbursement approval from the competent governmental authority in Belgium for its lead removal and peripheral atherectomy product line, effective October 1, 2007.

The reimbursement for the lead removal indication -- an embedded, infected lead or an electronic malfunction of a pacemaker or defibrillator electrode -- applies to hospitals in Belgium that meet the national cardiac pathology requirements and standards. The reimbursement for the peripheral indication applies to all centers in Belgium equipped with Spectranetics' technology for patients that suffer from critical limb ischemia with non-healing ulcers or rest pain due to infrapopliteal disease.

Shar Matin, Managing Director of Spectranetics International, B.V. commented, "We are very pleased that the Belgian authority granted reimbursement approval for our laser-based therapies. Belgian patients now have greater access to our life-changing technology. Reimbursement initiatives are a cornerstone of Spectranetics International's strategy and this approval follows the reimbursement approval in Germany for our peripheral atherectomy device earlier this year."

About Spectranetics

Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company's disposable catheters use high-energy "cool" ultraviolet light to vaporize arte
'/>"/>

SOURCE Spectranetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ICAGO, Dec. 3 Research ...evice and functional MRI (fMRI) have found that,c...ding to a study presented,today at the annual mee...,(RSNA). This is the first study using fMRI to map...n. , "We have shown that the brain has the ...
(Date:12/2/2008)...UISVILLE, Ky., Dec. 2 A...d meaningful images from the bits of information w... Grawemeyer Award for Psychology. , Anne Treism...y Professor,of psychology at Princeton Universit...ogy prize from among 28 nominations. , Trei...
(Date:12/2/2008)...A team of researchers from Monash University, The ...ical School and Vanda Pharmaceuticals has found a ...nd sleep disorders caused by shift work. , Dr S...of Psychology, Psychiatry and Psychological Medici...n receptors in the brain, could be a highly effect...
(Date:12/2/2008)...tients given Trasylol have a higher death risk, da...lthDay News) -- A new study casts more doubt on t...o limit bleeding in patients undergoing surgery. ,... in the United States, where it was removed from t... and Australian researchers reviewed findings from...
Breaking Medicine News(10 mins):Health News:Robotic Technology Improves Stroke Rehabilitation 2Health News:Robotic Technology Improves Stroke Rehabilitation 3Health News:Theory of How Brain Builds Images Earns Grawemeyer Prize 2Health News:New medication brings hope of jet lag cure 2Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2
... have said in the British Medical Journal that the...tals since 1990, based on mythical safety risks, a...phones were banned in hospitals after fears of the...and to prevent the potential confusion between the...
...ar 500,000 Americans develop pneumococcal pneumoni... serious, possibly fatal, illness. The October iss...g the word: A vaccine is available that helps prot...pneumonia and reduces the serious complications of...
... with allergic symptoms like wheezing, asthma, ha...nsitization to their infants too, according to a s...ts that the current practice of avoiding skin test... 4 or 5 should be reconsidered, so children in thi...
... a clear indication in a scientific journal regard...ing clinical trial//, the drug was tested on human...re drug reaction. But for the timely emergency car...ve been history. A Dutch report documenting the ...
Other Medicine News:Health News:Allergy Sufferers Pass on Allergies to their Children 2
(Date:12/1/2008)...wire-USNewswire/ -- A study has found that positro...imaging the breast, is not affected by either brea...rs that limit the effectiveness of standard mammog... presented today at the annual meeting of the Radi..., "The ability of PEM to detect cancer does not ...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)... December 9 at 11:00 am ET to Discuss Phase 2 Stud...O, Calif., Dec. 1 Sune...pharmaceutical company focused on the development ..., today announced new data from its studies of vor...sented during the 50th American Society of Hematol...
(Date:11/28/2008)...swire/ -- German biotech company,Partec is expand...oring and,AIDS patient follow-up diagnostics for ...08, 2.5 million patient tests have been performed ...CyFlow" system, supporting already,more than 1 mi...tion of the,Partec innovation, the average cost o...
Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Medifast Adds New Crunchy Bars to Product Line 28861 1Medifast Adds New Crunchy Bars to Product Line 28861 2NCPA Statement on November 4th Election Results 28860 1NCPA Statement on November 4th Election Results 28860 2ConjuChem Provides Development Update 8911 1ConjuChem Provides Development Update 8911 2ConjuChem Provides Development Update 8911 3State fund advances titanium powder research 9 other Iowa State projects 5736 1State fund advances titanium powder research 9 other Iowa State projects 5736 2State fund advances titanium powder research 9 other Iowa State projects 5736 3State fund advances titanium powder research 9 other Iowa State projects 5736 4
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
MONOJECT Red/Yellow Mottled Stopper
BD Vacutainer® Specialty Tubes - Thrombin
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
Medicine Products: